Thank you for your mail. Yes, I received my order and everithing is fine
with it. Thank you very much for the four extra pills you had, I really do
appreciate it.
I should recommand your site to friends and I'll come back to you soon.
Aurobindo Pharma receives US FDA approval - Express Pharma
Aurobindo Pharma receives US FDA approvalExpress PharmaAurobindo Pharma has received final approval from the US FDA to manufacture and market Lamivudine and Zidovudine tablets USP 150/300 mg (ANDA 202418) and is ready for launch.
Aurobindo Pharma receives final approval for Lamivudine+Zidovudine Tablets - Equity Bulls
Zee NewsAurobindo Pharma receives final approval for Lamivudine+Zidovudine TabletsEquity BullsAurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market for Lamivudine & Zidovudine tablets USP 150/300 mg (ANDA 202418) and is ready for launch.
South Africa exceeds 2007-11 treatment targets by 50% - aidsmap
South Africa exceeds 2007-11 treatment targets by 50%aidsmapCrude estimates of numbers of public sector patients on treatment in each quarter were calculated according to lamivudine (3TC, Epivir) sales figures from Aspen Pharmacare, which supplied 80% of lamivudine to the public sector until recently.
LANDMARK HIV DRUG'S PATENT EXPIRES TODAY - U-T San Diego
LANDMARK HIV DRUG'S PATENT EXPIRES TODAYU-T San DiegoThe FDA approved Combivir (lamivudine/zidovudine) in 1997, greatly changing the treatment of HIV/AIDS.
Patent expires of landmark HIV drug Combivir - U-T San Diego
Patent expires of landmark HIV drug CombivirU-T San DiegoThe FDA approved Combivir (lamivudine/zidovudine) in 1997, greatly changing the treatment of HIV/AIDS.